Seeking Alpha

GENZ Transcripts Search Results

Results 1-10 for Renagel (out of 17)
Refine your search:

You can use: AND, NOT, OR, " " (exact phrase)

Search across all Transcripts:

You can use: AND, NOT, OR, " " (exact phrase)


  • Genzyme Corporation Q3 2009 Earnings Call Transcript 21 Oct, 2009
    ... about 7% to $261 million, both Renagel and Renvella increased with greater unit ... haven't changed our strategy around Renagel Renvella. We still are moving ... care to patients. And Sevelamer, Renagel, Renvella is used by 50% ...
  • Genzyme Corporation Q2 2009 Earnings Call Transcript 22 Jul, 2009
    ... to cardio, metabolic, renal area increased by 4% to $243 million. This is due to increases in both Renagel and Renvela as well as continued strong performance of Thyrogen. Thyrogen increased by 9% on a year over year ...
  • Genzyme Corporation Q1 2009 Earnings Call Transcript 22 Apr, 2009
    ... and John Butler will talk about Renagel/Renvela with immersion briefly before we ... was due to continued demand for Renagel/Renvela as well as strong revenue ... the wholesale inventory levels for Renagel and Renvela are in the ...
  • Genzyme Q4 2008 Earnings Call Transcript 11 Feb, 2009
    ... somewhere around mid-year. We expect Renagel and Renvela to increase in ... Paragraph IV fillings on our Renagel patents. We remain extremely confident ... to be available before the Renagel patents expire. As mentioned before ...
  • Genzyme Corporation Q3 2008 Earnings Call Transcript 22 Oct, 2008
    ... as well as strong Fabrazym and Thyrogen revenue increases. Renagel volume increased by 11% and that was largely ... which is up 7.5% higher than an average Renagel prescription. Overall, share of the prescription phosphate ...
  • Genzyme Corp. Q2 2008 Earnings Call Transcript 23 Jul, 2008
    ... , so it's a very strong increase. Renagel increased 16%, again very solid and ... to the mix of Renvela versus Renagel in terms of scripts prior to ... , it's not just about switching Renagel patients to Renvela. This is about ...
  • Genzyme Corp. Q1 2008 Earnings Call Transcript 23 Apr, 2008
    ... action on the label change for Renagel and Renvela in terms of CKD ... United States as well as Europe. Renagel increased 23% due to strong end ... force physicians to switch well managed Renagel patients. Its early days in their ...
  • Genzyme Corp. Q4 2007 Earnings Call Transcript 13 Feb, 2008
    ... strong revenue performance for both Renagel and Hectorol was driven by ... to price Renvela equal to Renagel to drive this formulary placement. ... So, not really differentiating between Renagel and Renvela. Jim Birchenough - ...
  • Genzyme Q3 2007 Earnings Call Transcript 24 Oct, 2007
    ... The US represented about 58% of Renagel sales, including bulk sevelamer sales and ... the phosphate binding benefits of Renagel but also of sevelamer, but ... related benefits of Renvela versus Renagel to both patients and the ...
  • Genzyme Q2 2007 Earnings Call Transcript 25 Jul, 2007
    ... is about 2,000 patients worldwide. Renagel increased by 14% by strong ... clinical and economic story. The Renagel in new dialysis patients’ outcomes ... current pricing around -- of Renagel will carry it through Renvela. ...
Search GENZ Transcripts:

You can use: AND, NOT, OR, " " (exact phrase)

Most Popular Searches

in GENZ transcripts

Other Transcripts
from the Biotech Sector
  1. Arrowhead Research Corp. F4Q09 (Qtr End 09/30/09) Earnings Call Transcript
  2. Neogen Corporation F2Q10 (Qtr End11/30/09) Earnings Call Transcript
  3. Martek Biosciences Corporation F4Q09 (Qtr End 10/31/09) Earnings Call Transcript
To search across transcripts, find the most recent and most popular and view by sector, try: Seeking Alpha's Transcript Center